Back

Lighting the way to the future of heart failure management

2 September 2019 (13:40 - 13:55)
Organised by:
Congress Presentation Part of: Spotlight on the effects of SGLT2 inhibition in heart failure (EBAC accredited) Chronic Heart Failure ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Mikhail Kosiborod

St. Luke's Mid America Heart Institute, Kansas City (United States of America)

4 More presentations in this session

Presentation thumbnail
The hidden burden of heart failure
Professor F. Ruschitzka (Zurich, CH)
Slides Video
Presentation thumbnail
The clinical impact of SGLT2 inhibitor cardiovascular outcomes trials
Doctor M. Bonaca (Aurora, US)
Slides Video
Presentation thumbnail
SGLT2 inhibitors: uncovering the mechanisms of cardiovascular risk reduction
Professor S. Verma (Toronto, CA)
Slides Video
Presentation thumbnail
Questions and answers
Professor F. Ruschitzka (Zurich, CH) Doctor M. Bonaca (Aurora, US) Professor S. Verma (Toronto, CA) Doctor M. Kosiborod (Kansas City, US)
Slides Video

Access the full session

Session thumbnail
Spotlight on the effects of SGLT2 inhibition in heart failure (EBAC accredited)

The Event

Event poster

ESC Congress 2019

2 September 2019 13:40 CET
You may be interested in
thumbnail
Congress Session
Bridging gaps in heart failure care: primary care trends, exercise, kidney function, and global health perspectives
thumbnail
Congress Session
Nursing and Allied Professions Investigator Award
thumbnail
Congress Session
Which device might help your HFpEF patient?